Abstract
Drug development is time-consuming, costly, and risky. Approximate 80% to 90% of drug development projects fail before they ever get into clinical trials. To reduce the high risk of failure for drug development, pharmaceutical companies are exploring the drug repositioning approach for drug development. Previous studies have shown the feasibility of using computational methods to help extract plausible drug repositioning candidates, but they all encountered some limitations. In this study, we propose a novel drug-repositioning discovery method that takes into account multiple information sources, including more than 18,000,000 biomedical research articles and some existing ontologies that cover detailed relations between drugs, proteins and diseases. We design two experiments to evaluate our proposed drug repositioning discovery method. Overall, our evaluation results demonstrate the capability and superiority of our proposed drug repositioning method for discovering potential, novel drug-disease relationships.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adams, C.P., Brantner, V.V.: Estimating the cost of new drug development: Is it really $802 million? Health Aff. 25(2), 420–428 (2006)
National Institutes of Health. NIH Announces New Program to Develop Therapeutics for Rare and Neglected Diseases (May 20, 2009), http://rarediseases.info.nih.gov/files/TRND%20Press%20Release.pdf
Ashburn, T.T., Thor, K.B.: Drug repositioning: identifying and developing new uses for existing drugs. Nat. Rev. Drug Discov. 3(8), 673–683 (2004)
McBride, W.G.: Thalidomide and congenital abnormalities. Lancet 278(7216), 1358 (1961)
Stephens, T.D., Brynner, R.: Dark Remedy: The Impact of Thalidomide and Its Revival as a Vital Medicine. Perseus Publishing, Cambridge (2001)
Celgene Corporation: 2005 Annual Report. Celgene Corporation, Summit, NJ (2006)
Celgene Corporation: 2008 Annual Report on Form 10-K. Celgene Corporation, Summit, NJ (2009)
Celgene Corporation: 2012 Annual Report on Form 10-K. Celgene Corporation, Summit, NJ (2013)
Dudley, J.T., Deshpande, T., Butte, A.J.: Exploiting drug-disease relationships for computational drug repositioning. Brief. Bioinformatics 12, 303–311 (2011)
Hurle, M.R., Yang, L., Xie, Q., Rajpal, D.K., Sanseau, P., Agarwal, P.: Computational drug repositioning: From data to therapeutics. Clin. Pharmacol. Ther. 93(4), 335–341 (2013)
Emig, D., Ivliev, A., Pustovalova, O., Lancashire, L., Bureeva, S., Nikolsky, Y., Bessarabova, M.: Drug target prediction and repositioning using an integrated network-based approach. PLoS One 8(4), e60618 (2013)
Kim, S., Jin, D., Lee, H.: Predicting Drug-Target Interactions Using Drug-Drug Interactions. PLoS One 8(11), e80129 (2013)
Wu, Z., Wang, Y., Chen, L.: Network-based drug repositioning. Mol. Biosyst. 9, 1268–1281 (2013)
Swanson, D.R., Smalheiser, N.R.: An interactive system for finding complementary literatures: A stimulus to scientific discovery. Artif. Intell. 91(2), 183–203 (1997)
Knox, C., Law, V., Jewison, T., Liu, P., Ly, S., Frolkis, A., Wishart, D.S.: DrugBank 3.0: A comprehensive resource for ‘omics’ research on drugs. Nucleic Acids Res. 39(suppl. 1), D1035–D1041 (2011)
Hamosh, A., Scott, A.F., Amberger, J.S., Bocchini, C.A., McKusick, V.A.: Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Res. 33(suppl. 1), D514–D517 (2005)
Davis, A., King, B.L., Mockus, S., Murphy, C.G., Saraceni-Richards, C., Rosenstein, M., Mattingly, C.J.: The Comparative Toxicogenomics Database: Update 2013. Nucleic Acids Res. 39(suppl. 1), D1067–D1072 (2013)
Yetisgen-Yildiz, M., Pratt, W.: A new evaluation methodology for literature-based discovery systems. J. Biomed. Inform. 42(4), 633–643 (2009)
Swanson, D.R.: Fish oil, Raynaud’s syndrome, and undiscovered public knowledge. Perspect. Biol. Med. 30(1), 7–18 (1986)
Weeber, M., Klein, H., de Jong-van den Berg, L.T., Vos, R.: Using concepts in literature-based discovery: Simulating Swanson’s Raynaud–fish oil and migraine–magnesium discoveries. J. Am. Soc. Inf. Sci. Technol. 52(7), 548–557 (2001)
Wren, J.D., Bekeredjian, R., Stewart, J.A., Shohet, R.V., Garner, H.R.: Knowledge discovery by automated identification and ranking for implicit relationships. Bioinformatics 20(3), 389–398 (2004)
Lee, S., Choi, J., Park, K., Song, M., Lee, D.: Discovering context-specific relationships from biological literature by using multi-level context terms. BMC Medical Informatics and Decision Making (BMC Med. Inform. Decis. Mak.)Â 12(suppl. 1), S1 (2012)
Srinivasan, P.: Text mining: Generating hypotheses from MEDLINE. J. Am. Soc. Inf. Sci. Technol. 55(5), 396–413 (2004)
Hristovski, D., Peterlin, B., Mitchell, J.A., Humphrey, S.M.: Using literature-based discovery to identify disease candidate genes. Int. J. Med. Inform. 74, 289–298 (2005)
Frijters, R., van Vugt, M., Smeets, R., van Schaik, R., de Vlieg, J., Alkema, W.: Literature mining for the discovery of hidden connections between drugs, genes and diseases. PLoS Comput. Biol. 6(9), e1000943 (2010)
Lee, H.S., Bae, T., Lee, J.-H., Kim, D., Oh, Y., Jang, Y., Kim, S.: Rational drug repositioning guided by an integrated pharmacological network of protein, disease and drug. BMC Syst. Biol. 6(1), 80 (2012)
Campillos, M., Kuhn, M., Gavin, A.-C., Jensen, L.J., Bork, P.: Drug target identification using side-effect similarity. Science 321(5886), 263–266 (2008)
Yang, L., Agarwal, P.: Systematic drug repositioning based on clinical side-effects. PLOS ONEÂ 6(12), e28025 (2011)
Cheng, F., Liu, C., Jiang, J., Lu, W., Li, W., Liu, G., Tang, Y.: Prediction of drug-target interactions and drug repositioning via network-based inference. PLoS Comput. Biol. 8(5), e1002503 (2012)
Li, J., Lu, Z.: A new method for computational drug repositioning. In: IEEE International Conference on Bioinformatics and Biomedicine, pp. 1–4. IEEE Press, Philadelphia (2012)
Qu, X.A., Gudivada, R.C., Jegga, A.G., Neumann, E.K., Aronow, B.J.: Inferring novel disease indications for known drugs by semantically linking drug action and disease mechanism relationships. BMC Bioinformatics 10(suppl. 5), S4 (2009)
Li, J., Zhu, X., Chen, J.Y.: Building disease-specific drug-protein connectivity maps from molecular interaction networks and PubMed abstracts. PLoS Comput. Biol. 5(7), e1000450 (2009)
Cilibrasi, R.L., Vitányi, P.M.: The Google similarity distance. IEEE Trans. Knowl. Data Eng. 19(3), 370–383 (2007)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer International Publishing Switzerland
About this paper
Cite this paper
Wei, CP., Chen, KA., Chen, LC. (2014). Mining Biomedical Literature and Ontologies for Drug Repositioning Discovery. In: Tseng, V.S., Ho, T.B., Zhou, ZH., Chen, A.L.P., Kao, HY. (eds) Advances in Knowledge Discovery and Data Mining. PAKDD 2014. Lecture Notes in Computer Science(), vol 8444. Springer, Cham. https://doi.org/10.1007/978-3-319-06605-9_31
Download citation
DOI: https://doi.org/10.1007/978-3-319-06605-9_31
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-06604-2
Online ISBN: 978-3-319-06605-9
eBook Packages: Computer ScienceComputer Science (R0)